Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Fusidic acid successfully treated a rare scalp infection with hair regrowth and no recurrence after 6 months.

Tofacitinib treatment is used for teenagers with alopecia areata.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Flibanserin shows promise for treating male sexual dysfunction but has side effects like insomnia and fatigue.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

HIV medication ritonavir can increase the effects of nasal sprays like fluticasone, causing Cushing's syndrome.

Kang'ai injection with FLO chemotherapy improves effectiveness and quality of life in advanced gastric cancer patients.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

Dutasteride is more effective than finasteride for hair growth with similar side effects.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Oral tofacitinib is more effective than oral minoxidil for treating alopecia areata.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Oral dutasteride is a recommended first treatment for frontal fibrosing alopecia.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

5% minoxidil foam helps women with thinning hair.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Tapering and stopping tofacitinib may be possible for young alopecia areata patients.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Finasteride increases P-glycoprotein activity in the liver and kidney.